title: Endocrinological effects of treatment with high doses of medroxyprogesterone acetate in patients with renal or prostatic adenocarcinoma.
authors.affiliation: Department of Urology & Andrology, University of Umeå, Sweden.
authors.forename: R
authors.initials: R
authors.lastname: Tomic
authors.forename: B
authors.initials: B
authors.lastname: Ljungberg
authors.forename: J E
authors.initials: JE
authors.lastname: Damber
mesh_terms: D000230:Adenocarcinoma / Q000188:drug therapy*; D000728:Androgens / Q000378:metabolism; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008525:Medroxyprogesterone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017258:Medroxyprogesterone Acetate; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D012738:Sex Hormone-Binding Globulin / Q000187:drug effects
chemical_list: D000728:Androgens; D000970:Antineoplastic Agents; D012738:Sex Hormone-Binding Globulin; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone